UNSPSC 51132208: Acetaminophen/aspirin/calcium carbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51132208 Acetaminophen/aspirin/calcium carbonate (Commodity) covers over-the-counter pain relief and antacid formulations, though recent state and local solicitations tagged under this code show substantial divergence from the nominal category scope. The code appears in procurements spanning emergency medical supplies (naloxone and drug deactivation systems), direct-to-manufacturer pharmacy benefit programs, and multi-state cooperative purchasing for generic pharmaceuticals and OTC products. Issuing bodies include county public health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work involves establishing supply agreements, defining manufacturer-wholesaler relationships, and managing competitive bidding and RFP processes for pharmaceutical inventory across government health systems and employee benefit programs.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and compliance requirements including drug-free workplace certification and E-Verify. The Texas HHS Commission issued an RFI (HHS0017013, April 3, 2026) to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP, administered by Minnesota's Department of Administration, posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson), requiring NDC-level product detail, cGMP and DSCSA certification, and pricing through various net-price formats. The mismatch between the code's nominal scope and naloxone procurement suggests inconsistent coding; core pharmaceutical supply and cooperative purchasing activity dominates the recent record.